Shummi Jindal
Managing Partner
Get their honest, personalized take on your startup.
Sign in to pitch Shummi →At a glance
- Full Name
- Shummi Jindal
- Title
- Managing Partner
- Firm
- Hudson Park Advisors
- Firm Type
- Registered Investment Advisor / Angel Investor (early-stage participation)
- Investment Stage
- Seed / Series A
- Sector Focus
- Healthcare technology and life-sciences SaaS (based on disclosed deals); the firm broadly covers capital markets, private lending, and real estate
- Geographic Focus
- United States (New York–centric)
- Location
- New York, NY
Background
Shummi Jindal is a Managing Partner at Hudson Park Advisors, a Manhattan-based Registered Investment Advisor with an additional office in New York's Hudson Valley. The firm describes itself as a provider of capital markets, private lending, and real estate investment management services to a select group of individuals, families, and small businesses. It is a small operation — roughly 5–6 employees — and was founded around 2010. Alongside Jindal, the firm's leadership includes Glen Vetromile, a Principal/Managing Partner focused on real estate investment and management.
Jindal built his career in institutional finance before moving into the advisory and early-stage investing world. He began as an Analyst at Goldman Sachs (2006–2007), then spent roughly four years as an Associate at Summit Rock Advisors (2007–2011), an outsourced-CIO and ultra-high-net-worth investment management firm in New York. He subsequently earned his MBA from New York University's Leonard N. Stern School of Business (2014–2015).
In his current role, Jindal helps direct Hudson Park's investment activity, which spans traditional advisory services and a small number of direct early-stage venture investments. Public databases attribute a modest portfolio to the firm, concentrated in seed and Series A rounds. Note that much of the detailed data on Jindal circulates through contact-aggregator sites (RocketReach, ZoomInfo, Apollo, Success.ai); the firm's own website was offline during research, so firm-published biographical detail could not be independently confirmed.
Investment Thesis & Focus
- Invests at the seed and Series A stages, typically as a participating (non-lead) investor alongside larger venture firms.
- Disclosed activity points toward healthcare technology and life-sciences software — e.g., cloud/SaaS platforms serving pharma and biotech.
- Operates within a broader Hudson Park mandate spanning capital markets, private lending, and real estate, so venture is one of several capital-deployment avenues rather than a dedicated fund.
- Targets a select, relationship-driven client and deal base ("a select group of individuals, families and small businesses"), consistent with a boutique RIA model.
- Note: a specific, publicly stated personal investment thesis or check-size range from Jindal himself could not be verified.
Notable Investments
- QbDVision — Cloud-based "digital CMC" SaaS platform for biopharmaceutical process development and biomanufacturing. Hudson Park Advisors (also referenced as Hudson Park Capital) participated in QbDVision's $15M Series A (February 2022), a round led by Northpond Ventures with S3 Ventures and Wanxiang Healthcare Investments.
- Undisclosed seed-stage company — Aggregator data (CB Insights) records an earlier seed-round investment dated January 30, 2019; the company name is behind a paywall and could not be verified.
Unlock the full research
Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.
One-time. Stays unlocked for you.